Prognostic value of PSMA PET/CT in prostate cancer
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in
the majority of prostate cancer (PCa). PSMA has an enzymatic function that makes metabolic …
the majority of prostate cancer (PCa). PSMA has an enzymatic function that makes metabolic …
[HTML][HTML] Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer?
R Laudicella, M Bauckneht, IA Burger - Seminars in Nuclear Medicine, 2024 - Elsevier
While RECIST 1.1 is well established in radiological response assessment, it is of limited
use in prostate cancer (PCa) considering that the disease is often seen only as sclerotic …
use in prostate cancer (PCa) considering that the disease is often seen only as sclerotic …
Role of volumetric parameters obtained from 68 Ga-PSMA PET/CT and 18F-FDG PET/CT in predicting overall survival in patients with mCRPC receiving taxane …
Y Güzel, H Kömek, C Can, İ Kaplan, N Akdeniz… - Annals of Nuclear …, 2023 - Springer
Objective The aim of this study was to determine the prognostic role of volumetric
parameters and Pro-PET scores obtained from 68 Ga-prostate-specific membrane antigen …
parameters and Pro-PET scores obtained from 68 Ga-prostate-specific membrane antigen …
Prostate-specific membrane antigen positron emission tomography as a biomarker to assess treatment response in patients with advanced prostate cancer
B Esen, K Herrmann, S Bavbek, Y Kordan, D Tilki… - European Urology …, 2023 - Elsevier
Context Prostate-specific membrane antigen (PSMA)-targeted positron emission
tomography (PET) has superior accuracy for detection of metastatic lesions in patients with …
tomography (PET) has superior accuracy for detection of metastatic lesions in patients with …
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients
EF Giunta, P Caroli, E Scarpi, A Altavilla… - European Journal of …, 2024 - Springer
Purpose to assess the utility of response monitoring to enzalutamide by using [68Ga] Ga-
PSMA PET in mCRPC patients treated with enzalutamide as first-line therapy. Methods …
PSMA PET in mCRPC patients treated with enzalutamide as first-line therapy. Methods …
[HTML][HTML] A Comprehensive Analysis of Volumetric 68Ga-PSMA PET/CT Parameters, Clinical and Histopathologic Features: Evaluation of the Predictive Role
G Mutevelizade, Y Parlak, CS Arıkbası… - Mol Imaging …, 2024 - jag.journalagent.com
BULGULAR: GS ve primer prostat tümöründen elde edilen SUVmax, serum PSA düzeyleri
ile anlamlı olarak ilişkiliydi (p< 0.05). PSA düzeyleri ve SUVmax değerleri lenf nodu …
ile anlamlı olarak ilişkiliydi (p< 0.05). PSA düzeyleri ve SUVmax değerleri lenf nodu …
[HTML][HTML] PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant …
F Kleiburg, LF de Geus-Oei, SAC Luelmo… - European journal of …, 2024 - Elsevier
Background In metastatic castration-resistant prostate cancer (mCRPC), using serum
prostate-specific antigen (PSA) levels to evaluate treatment response is not always accurate …
prostate-specific antigen (PSA) levels to evaluate treatment response is not always accurate …
Should new organ involvement be included in Response Evaluation Criteria in PSMA Imaging?
İ Kaplan, H Kömek, C Can, N Akdeniz, Y Güzel… - Annals of Nuclear …, 2024 - Springer
Purpose The current study is intended to investigate the effect of new organ involvement on
overall survival (OS) and modify the Response Evaluation Criteria in PSMA Imaging …
overall survival (OS) and modify the Response Evaluation Criteria in PSMA Imaging …
Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer …
Objective We aimed to evaluate whether baseline 68Ga-PSMA PET/CT-derived whole-body
volumetric parameters could be used as predictive biomarkers for survival in metastatic …
volumetric parameters could be used as predictive biomarkers for survival in metastatic …
Whole-body tumor burden in PET/CT expert review
DF Santos, ME Takahashi, M Camacho… - Clinical and …, 2023 - Springer
Introduction PET/CT whole-body tumor burden (WBTB), as a measure for overall burden of
cancer, has been shown bear a strong correlation with prognosis. In the last decade, there …
cancer, has been shown bear a strong correlation with prognosis. In the last decade, there …